Moderna, Inc. (MRNA)
NASDAQ: MRNA · Real-Time Price · USD
35.74
+0.08 (0.22%)
Jan 7, 2026, 11:26 AM EST - Market open
Moderna Employees
Moderna had 5,800 employees as of December 31, 2024. The number of employees increased by 200 or 3.57% compared to the previous year.
Employees
5,800
Change (1Y)
200
Growth (1Y)
3.57%
Revenue / Employee
$384,828
Profits / Employee
-$537,241
Market Cap
13.96B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 5,800 | 200 | 3.57% |
| Dec 31, 2023 | 5,600 | 1,700 | 43.59% |
| Dec 31, 2022 | 3,900 | 1,200 | 44.44% |
| Dec 31, 2021 | 2,700 | 1,400 | 107.69% |
| Dec 31, 2020 | 1,300 | 470 | 56.63% |
| Dec 31, 2019 | 830 | 70 | 9.21% |
| Dec 31, 2018 | 760 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
MRNA News
- 2 hours ago - Moderna Stock Fights Back Against Four‑Year Curse With 20% Blastoff And A Golden Cross - Benzinga
- 23 hours ago - America's new vaccine doctrine for children replaces data with dogma - Market Watch
- 2 days ago - Moderna Announces Global Regulatory Submissions for Its Investigational Seasonal Influenza Vaccine - Accesswire
- 20 days ago - Moderna secures up to $54.3 million funding for bird flu vaccine from global coalition - Reuters
- 20 days ago - CEPI to Fund Pivotal Phase 3 Trial for Moderna's mRNA Pandemic Influenza Vaccine Candidate - Accesswire
- 21 days ago - Moderna to Present at the 44th Annual J.P. Morgan Healthcare Conference - Accesswire
- 23 days ago - EMA Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Authorization of Moderna's mNEXSPIKE (COVID-19 Vaccine, mRNA) - Accesswire
- 5 weeks ago - Moderna, Inc. (MRNA) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript - Seeking Alpha